| payload |
{"created_at":"2026-04-07T03:18:43.308 {"created_at":"2026-04-07T03:18:43.308311+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:e85d91c2389e710f","evidence_event_ids":["evt_529da0b57bab"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001636178-26-000006.txt","as_of":"2026-04-07T03:18:43.308311+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001636178-26-000006.txt","company":"UNITED THERAPEUTICS Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001636178-26-000006.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_1f4ec93e4cd8bfc1","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001636178-26-000006.txt","content_type":"text/plain","enriched_at":"2026-04-07T08:17:58.477857+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001636178-26-000006.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001636178-26-000006.txt","source_event_id":"evt_529da0b57bab","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"1950f2818a6546ca","kind":"sec_filing","published_at":"20260406","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-06","2026-04-02"],"entities":[{"asset_class":"equity","name":"United Therapeutics Corp","relevance":"issuer","symbol":"UTHR","type":"company"}],"event_type":"listing","information_gaps":["No prior state of stock transactions provided for comparison."],"key_facts":["Filing date: April 6, 2026","Form type: 4","Reporting owner: James Edgemond, CFO","Transactions included stock options and sales of common stock"],"numeric_claims":[{"label":"Total shares sold","value":"10000"},{"label":"Stock option exercise price","value":"135.42"}],"primary_claim":"United Therapeutics Corp filed a Form 4 on April 6, 2026, detailing stock transactions by CFO James Edgemond.","relevance_score":0.8,"sentiment":"neutral","source_quality":"high","summary":"United Therapeutics Corp filed a Form 4 on April 6, 2026, disclosing stock transactions by CFO James Edgemond, including the exercise of stock options and sales of common stock.","topics":["SEC filing","stock transactions","executive compensation"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 UNITED THERAPEUTICS Corp \u00b7 Filed 20260406","ticker":"UTHR","tickers":["UTHR"],"title":"UTHR filed 4","url":"https://www.sec.gov/Archives/edgar/data/1082554/0001636178-26-000006.txt"}}... |